[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-05-07-4":3},{"date":4,"filings":5,"has_more":605,"limit":606,"page":607,"total_count":608},"2026-05-07",[6,14,22,29,36,43,50,57,64,71,78,85,91,97,103,110,115,120,126,131,136,141,148,153,160,167,174,181,186,191,196,201,206,211,218,224,230,237,243,250,257,264,269,274,281,286,292,298,304,311,316,321,326,333,340,347,352,357,364,371,378,384,389,395,400,405,410,416,423,430,437,442,447,454,459,466,471,478,483,488,493,498,504,509,514,520,526,533,540,545,550,555,560,565,570,575,582,589,594,599],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"Snowman Logistics Ltd","2026-05-07T20:11:41.594000","BSE","Q4 & FY26 Earnings Call Recording Link Shared","69fca4f5abd16353d2ffb09e","SNOWMAN","- The company has submitted the audio recording of its earnings conference call held on May 7, 2026.\n- This call discussed the audited financial results for the quarter and year ended March 31, 2026.\n- This filing is a procedural update providing a link to the recording and does not contain the financial results themselves.",{"company_name":15,"filing_date":16,"filing_source":17,"headline":18,"id":19,"stock_code":20,"summary_text":21},"Mahanagar Gas Limited","2026-05-07T20:11:40.531000","NSE","FY26 Results: Revenue Up 14%, but Profit Plummets 19%","69fca4eef35e30561cff9641","MGL","*   **Revenue Growth:** Gross Revenue from Operations grew 13.58% YoY to ₹9,059.77 Crores, driven by an 8.25% increase in sales volume.\n*   **Profit Decline:** Profit After Tax (PAT) fell sharply by 18.67% YoY to ₹846.82 Crores. EBITDA margin compressed significantly from 21.62% to 17.61% due to higher gas purchase costs.\n*   **Dividend Declared:** The Board recommended a Final Dividend of ₹18.00 per share, bringing the total dividend for FY26 to ₹30.00 per share.\n*   **Contingent Liabilities:** The company faces unprovisioned contingent liabilities of approximately ₹386 Crore from two major legal disputes (GAIL & GST), which management believes have a strong chance of being won.\n*   **Amalgamation:** Financials for the previous year (FY25) have been restated following the amalgamation of its subsidiary, Unison Enviro Private Limited (UEPL).",{"company_name":23,"filing_date":24,"filing_source":17,"headline":25,"id":26,"stock_code":27,"summary_text":28},"Orient Green Power Company Limited","2026-05-07T20:11:40.271000","Schedules Investor Call for Q4 & FY26 Results","69fca4cdec7f5de862c57600","GREENPOWER","*   The company will host an \"Earnings Conference Call\" to discuss financial results for the fourth quarter (Q4) and the full financial year FY26.\n*   The call is scheduled for Wednesday, May 13, 2026, at 11:00 AM onwards.\n*   Investors and analysts can join via a pre-registration link or universal dial-in numbers.\n*   This call provides a direct opportunity for stakeholders to engage with the company's management regarding performance and future outlook.",{"company_name":30,"filing_date":31,"filing_source":17,"headline":32,"id":33,"stock_code":34,"summary_text":35},"Goa Carbon Limited","2026-05-07T20:11:40.223000","FY26 Loss Doubles to ₹48 Cr; Board Skips Dividend Despite Q4 Profit","69fca4fc5236ec998939fa5b","GOACARBON","• \u003Cb>Full-Year Loss Widens:\u003C\u002Fb> Net Loss for FY26 more than doubled to ₹48.23 crore, up 119% from a ₹22.02 crore loss in FY25, driven by higher material and finance costs.\n• \u003Cb>Q4 Turnaround:\u003C\u002Fb> The company returned to profitability in Q4 FY26 with a Net Profit of ₹4.49 crore, compared to a loss of ₹6.54 crore in Q4 FY25.\n• \u003Cb>No Dividend:\u003C\u002Fb> The Board has not recommended a final dividend for the financial year 2025-26 in view of the annual loss.\n• \u003Cb>Revenue Growth:\u003C\u002Fb> Despite the loss, full-year Income from Operations grew 37% YoY to ₹696.42 crore.\n• \u003Cb>Plant Shutdowns:\u003C\u002Fb> Key plants faced extended shutdowns in Q4 for maintenance and operational optimization, with the Goa plant shut for 82 days and the Bilaspur plant for 90 days.\n• \u003Cb>Auditor's Opinion:\u003C\u002Fb> Statutory auditors issued an Unmodified Opinion on the financial results.",{"company_name":37,"filing_date":38,"filing_source":17,"headline":39,"id":40,"stock_code":41,"summary_text":42},"Hindustan Unilever Limited","2026-05-07T20:11:40.014000","HUL Posts Strongest Quarterly Growth in 3 Years, But Warns of Inflation","69fca4fbf43b112c8d9214c2","HINDUNILVR","*   Q4 FY26 saw the highest growth in 12 quarters, with Underlying Sales Growth (USG) at 8% and Underlying Volume Growth (UVG) at 6%.\n*   The Home Care segment was a standout performer, delivering its strongest growth in 11 quarters at 9% USG, driven by Fabric and Household Care.\n*   For the full year (FY26), the company achieved a turnover of ₹63,763 crores with 5% USG and an EBITDA margin of 23.6%.\n*   Management flagged significant risk from the Middle East crisis, anticipating 8-10% material cost inflation and planning further price hikes.\n*   The Board announced a final dividend of ₹22\u002Fshare (totaling ₹41\u002Fshare for FY26) and confirmed the strategic demerger of its Ice Cream business.\n*   Management expects FY27 to be better than FY26 and maintains its mid-term EBITDA margin guidance of 22.5% to 23.5%.",{"company_name":44,"filing_date":45,"filing_source":17,"headline":46,"id":47,"stock_code":48,"summary_text":49},"Sandur Manganese & Iron Ores Limited","2026-05-07T20:11:39.943000","FY26 Results: Revenue Jumps 62% & Bonus Issued, but Faces Major Legal Risk","69fca4f4bf8f716f13ffa690","SANDUMA","*   Consolidated revenue for FY26 surged 62% YoY to ₹5,08,842 lakh, driven by strong growth in Steel (+159%) and Ferroalloys (+205%) segments.\n*   The company issued 2:1 bonus shares (allotted Sep 2025) and has now recommended a final dividend of ₹0.5 per share for FY26.\n*   \u003Cb>RED FLAG:\u003C\u002Fb> A High Court order has demanded ₹13,125 lakh in afforestation charges. The company is appealing to the Supreme Court, representing a significant contingent liability.\n*   Strengthened its balance sheet by making an early redemption of Non-Convertible Debentures (NCDs) worth ₹42,300 lakh through internal accruals.\n*   Reported a one-time, non-recurring charge of ₹3,227 lakh due to new Labour Codes, which has impacted the year's net profit.",{"company_name":51,"filing_date":52,"filing_source":17,"headline":53,"id":54,"stock_code":55,"summary_text":56},"Ugro Capital Limited","2026-05-07T20:11:39.865000","Raises ₹22.02 Crore via Commercial Papers","69fca4d258d87443453a080c","UGROCAP","*   Raised **₹22.02 Crores** through the issuance and allotment of Commercial Papers (CPs), a form of short-term debt.\n*   The CPs have a tenure of 180 days, with a total redemption value of **₹23 Crores** due on November 3, 2026.\n*   The issue carries an implicit yield of approximately **8.99% per annum**, reflecting the company's current short-term borrowing cost.\n*   Funds are intended to support short-term working capital requirements and lending operations.",{"company_name":58,"filing_date":59,"filing_source":17,"headline":60,"id":61,"stock_code":62,"summary_text":63},"Thyrocare Technologies Limited","2026-05-07T20:11:39.645000","Board Recommends ₹7 Dividend, Approves Strategic Expansion & Key Leadership Changes","69fca4e4ecaa861d94922410","THYROCARE","• The Board has recommended a final dividend of ₹7.00 per equity share for FY 2025-26.\n• Approves a major strategic shift to expand into a broader healthcare ecosystem (hospitals, digital health, medical devices) by altering the company's charter (MOA).\n• Announces significant board changes, strengthening the control of parent company API Holdings (PharmEasy), with the re-appointed CEO and two new directors all being senior executives from the parent.\n• To invest ₹5.50 Crores into its subsidiary, Think Health Diagnostics, despite the subsidiary's turnover collapsing from ₹3.35 Cr to ₹0.01 Cr over the last three years.\n• Proposes appointing \"Big Four\" firm PwC as the new Statutory Auditor.",{"company_name":65,"filing_date":66,"filing_source":17,"headline":67,"id":68,"stock_code":69,"summary_text":70},"CCL Products (India) Limited","2026-05-07T20:11:39.618000","Board Recommends Final Dividend of ₹3 Per Share for FY26","69fca4c9abd16353d2ffb099","CCL","*   The Board of Directors has approved the audited financial results for the financial year ended March 31, 2026.\n*   A final dividend of **₹3 per equity share** (150% of face value) has been recommended for the financial year 2025-26.\n*   This dividend is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).",{"company_name":72,"filing_date":73,"filing_source":17,"headline":74,"id":75,"stock_code":76,"summary_text":77},"Vijaya Diagnostic Centre Limited","2026-05-07T20:11:39.443000","Delivers Landmark Year with Record Revenue & Margin Expansion","69fca4fea157653c663a122c","VIJAYA","*   \u003Cb>Record Performance:\u003C\u002Fb> Achieved highest-ever quarterly revenue of ₹219.4 Cr in Q4 FY26 (up 26.6% YoY). Full-year revenue crossed ₹800 Cr, growing 19.5% YoY and outperforming guidance.\n*   \u003Cb>Profitability & Margins:\u003C\u002Fb> Q4 EBITDA margin expanded significantly to 43.5% (+379 bps YoY). Full-year net profit grew 20.3% to ₹173.0 Cr.\n*   \u003Cb>Volume Growth:\u003C\u002Fb> Overall test volumes increased by 18.5% YoY in Q4, with the high-growth Wellness segment surging by 32.2%.\n*   \u003Cb>Strategic Expansion:\u003C\u002Fb> Successfully integrated the Medinova merger, expanding its Kolkata footprint. FY27 plans include adding 4 new hubs, 10 spokes, and launching advanced genomic testing.",{"company_name":79,"filing_date":80,"filing_source":17,"headline":81,"id":82,"stock_code":83,"summary_text":84},"Blue Pebble Limited","2026-05-07T20:11:39.400000","Board Meeting Scheduled to Approve Annual Financial Results","69fca4ce0c6b4fb98a922f00","BLUEPEBBLE","• A meeting of the Board of Directors is scheduled for 15-May-2026.\n• The primary agenda is to consider and approve the Audited Standalone and Consolidated Financial Results for the financial year ended 31-March-2026.\n• This filing is a mandatory intimation under SEBI (LODR) regulations.",{"company_name":86,"filing_date":87,"filing_source":9,"headline":88,"id":89,"stock_code":48,"summary_text":90},"Sandur Manganese & Iron Ores Ltd","2026-05-07T20:06:40.824000","Posts Strong FY26 Results, De-leverages Balance Sheet but Faces ₹13,125 Lakh Legal Risk","69fca3db58d87443453a0807","*   \u003Cb>Strong Growth:\u003C\u002Fb> Consolidated revenue from operations grew 62% YoY to ₹5,08,842 lakh for FY26, driven by the Steel and Ferroalloys segments.\n*   \u003Cb>Significant Deleveraging:\u003C\u002Fb> The company used internal accruals for an early redemption of Non-Convertible Debentures (NCDs) worth ₹42,300 lakh, strengthening its balance sheet.\n*   \u003Cb>Shareholder Returns:\u003C\u002Fb> The Board recommended a final dividend of ₹0.5 per share. This follows a 2:1 bonus issue completed in September 2025.\n*   \u003Cb>Major Legal Risk:\u003C\u002Fb> The Karnataka High Court has ruled against the company in a case involving a ₹13,125 lakh demand for Compensatory Afforestation charges. The company plans to appeal to the Supreme Court, representing a material contingent liability.",{"company_name":92,"filing_date":93,"filing_source":9,"headline":94,"id":95,"stock_code":76,"summary_text":96},"Vijaya Diagnostic Centre Ltd","2026-05-07T20:06:40.727000","Posts Record Quarterly Revenue & Outperforms Annual Guidance","69fca3c6ec7f5de862c575fc","• \u003Cb>Record Q4 Performance:\u003C\u002Fb> Revenue grew 26.6% YoY to ₹2,193.8 Mn, the highest ever for a quarter. PAT increased by 37.5% YoY.\n• \u003Cb>Strong Margin Expansion:\u003C\u002Fb> Q4 EBITDA margin improved significantly to 43.5% from 39.8% a year ago.\n• \u003Cb>Outperforming Guidance:\u003C\u002Fb> FY26 revenue growth translates to a 16.5% CAGR since listing, beating the 15% guidance. EBITDA margins also remained ahead of the 40% guidance.\n• \u003Cb>Successful Expansion:\u003C\u002Fb> New hubs in Khammam, Nandyal, and Pune achieved rapid break-even, reinforcing confidence in the company's growth model.\n• \u003Cb>FY27 Outlook:\u003C\u002Fb> Plans include continued network expansion (4-5 new hubs), launching advanced genomic testing, and building a new automated lab in Hyderabad.",{"company_name":98,"filing_date":99,"filing_source":9,"headline":100,"id":101,"stock_code":27,"summary_text":102},"Orient Green Power Company Ltd","2026-05-07T20:06:40.692000","Announces Q4 & FY26 Earnings Call","69fca3acecaa861d94922409","• The company will host an earnings conference call to discuss its financial results for the fourth quarter (Q4) and the full financial year 2026.\n• The call is scheduled for Wednesday, May 13, 2026, at 11:00 AM.\n• This filing is an intimation of the upcoming event; it does not contain the financial results themselves.",{"company_name":104,"filing_date":105,"filing_source":9,"headline":106,"id":107,"stock_code":108,"summary_text":109},"Muthoot Microfin Ltd","2026-05-07T20:06:40.645000","FY26 Net Profit Jumps 67% on Strong Revenue Growth","69fca3bdf43b112c8d9214bd","MUTHOOTMF","*   \u003Cb>Net Profit (FY26):\u003C\u002Fb> ₹736.19 Cr, a 66.7% increase year-over-year.\n*   \u003Cb>Total Income (FY26):\u003C\u002Fb> ₹2,948.41 Cr, a 45.0% increase year-over-year.\n*   \u003Cb>Earnings Per Share (FY26):\u003C\u002Fb> ₹43.22, up from ₹25.93 in the previous year.\n*   \u003Cb>Improved Leverage:\u003C\u002Fb> Debt Equity Ratio improved to 3.39 from 3.93 a year ago.\n*   \u003Cb>Stable Rating:\u003C\u002Fb> Credit rating maintained at 'A+\u002FStable' from both CRISIL and ICRA.",{"company_name":15,"filing_date":111,"filing_source":17,"headline":112,"id":113,"stock_code":20,"summary_text":114},"2026-05-07T20:06:39.865000","FY26 Results: Revenue Grows 14%, But Profits Plunge 19% on Higher Costs","69fca3d0bf8f716f13ffa68b","- Revenue from Operations grew 13.6% YoY to ₹9,060 Cr, but Profit After Tax (PAT) fell sharply by 18.7% to ₹847 Cr.\n- The profit decline was driven by a 20.4% surge in gas purchase costs, leading to severe margin compression (PAT margin fell from 14.34% to 10.28%).\n- The Board has recommended a Final Dividend of ₹18.00 per share. This brings the total dividend for FY 2025-26 to ₹30.00 per share.\n- The company faces significant unprovisioned contingent liabilities of over ₹386 Crore from ongoing legal disputes with GAIL and the GST department.",{"company_name":58,"filing_date":116,"filing_source":17,"headline":117,"id":118,"stock_code":62,"summary_text":119},"2026-05-07T20:06:39.860000","Board Meeting Highlights: Strategic Pivot, Parent Co. Influence Grows & Questionable Investment","69fca3bbc9cbead9b3c585be","*   The Board recommended a final dividend of ₹7.00 per share for the financial year 2025-26.\n*   A major strategic pivot is planned, altering the company's charter (MOA) to expand from pure diagnostics into managing hospitals, digital health platforms, and manufacturing medical devices.\n*   Two senior executives from the ultimate parent company, API Holdings (PharmEasy), have been appointed to the Board, significantly increasing the parent's influence.\n*   A fresh investment of ₹5.5 Crores was approved for the subsidiary \"Think Health Diagnostics,\" despite its turnover collapsing from ₹3.35 Crores in FY24 to just ₹0.01 Crores in FY26, raising a major red flag.\n*   The Board proposed changing the statutory auditor to M\u002Fs. Price Waterhouse Chartered Accountants LLP, replacing the retiring M\u002Fs. MSKA & Associates LLP.",{"company_name":121,"filing_date":122,"filing_source":17,"headline":123,"id":124,"stock_code":108,"summary_text":125},"Muthoot Microfin Limited","2026-05-07T20:06:39.577000","FY26 Profits Surge 54%, but Q4 EPS Dips on Equity Dilution","69fca3bb0c6b4fb98a922ef5","*   **Strong Annual Growth:** For the full financial year (FY26), Net Profit surged by 54.3% YoY to ₹555.25 crore, while Total Income grew by 40.0% YoY.\n*   **Quarterly EPS Dip:** Despite strong profits, Basic EPS for Q4 FY26 declined by 4.1% YoY to ₹8.94.\n*   **Equity Dilution Impact:** The quarterly EPS drop was primarily caused by a 32.5% increase in the company's paid-up equity share capital during the year.\n*   **Full-Year EPS:** For the full financial year, Basic EPS still grew by a healthy 23.7% to ₹36.90, as annual profit growth outpaced the dilution.",{"company_name":58,"filing_date":127,"filing_source":17,"headline":128,"id":129,"stock_code":62,"summary_text":130},"2026-05-07T20:06:39.571000","Board Overhaul, Strategic Expansion & Dividend Declared","69fca3bda157653c663a1226","*   \u003Cb>Strategic Shift:\u003C\u002Fb> The Board approved a major expansion of the company's business scope beyond diagnostics into hospitals, digital health, and pharmaceuticals, signaling a new strategic direction.\n*   \u003Cb>Governance Changes:\u003C\u002Fb> Key executives from the parent company, API Holdings (PharmEasy), have been appointed to the Board, strengthening its control. The CEO, Mr. Rahul Guha, has been re-appointed for 5 years.\n*   \u003Cb>Dividend Declared:\u003C\u002Fb> A final dividend of ₹7.00 per share has been recommended for the financial year 2025-26.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The company will invest ₹5.5 Crores into its subsidiary, 'Think Health Diagnostics', despite its turnover collapsing from ₹3.35 Crores to ₹0.01 Crores over the last two years.",{"company_name":72,"filing_date":132,"filing_source":17,"headline":133,"id":134,"stock_code":76,"summary_text":135},"2026-05-07T20:06:39.513000","Posts Record-Breaking Q4 Revenue & Beats Annual Guidance","69fca3c9abd16353d2ffb094","*   Reported its highest-ever quarterly revenue of ₹219.38 Crores, a 26.6% YoY increase.\n*   EBITDA margins expanded significantly to 43.5% for the quarter (up 379 bps YoY), reflecting strong operational efficiency.\n*   Outperformed its long-term guidance, with FY26 revenue growth of 19.5% and an EBITDA margin of 41.4%.\n*   Demonstrated a successful expansion model with new hubs achieving rapid break-even; plans for further network growth and new genomic testing in FY27.",{"company_name":65,"filing_date":137,"filing_source":17,"headline":138,"id":139,"stock_code":69,"summary_text":140},"2026-05-07T20:06:39.466000","CCL Announces ESOP Grants and Redefines Senior Management","69fca3a3890e096a6fc590b4","*   The Nomination and Remuneration Committee has approved the grant of 1,61,850 stock options to eligible employees under the \"CCL Employee Stock Option Scheme-2022\".\n*   The exercise price for these options is set at face value, which is ₹2\u002F- per share, representing a significant value transfer to employees.\n*   The company has also redefined its Senior Management Personnel, formalizing a list of 6 key leaders including the CEO, CFO, and Company Secretary.\n*   The filing was made on May 7, 2026, in compliance with SEBI's LODR regulations.",{"company_name":142,"filing_date":143,"filing_source":9,"headline":144,"id":145,"stock_code":146,"summary_text":147},"V-Mart Retail Ltd","2026-05-07T20:01:41.818000","FY26 Profits Soar, Announces 3:1 Bonus Share Issue","69fca2a25236ec998939fa4e","VMART","*   \u003Cb>Bonus Share Issue:\u003C\u002Fb> The company has announced a bonus issue of 3 equity shares for every 1 fully paid-up equity share held.\n*   \u003Cb>Stellar Profit Growth:\u003C\u002Fb> Consolidated Profit After Tax (PAT) surged 171% YoY to ₹1,240 Mn for FY26.\n*   \u003Cb>Strong Revenue:\u003C\u002Fb> Total revenue from operations grew 16% YoY to ₹37,894 Mn, with Same Store Sales Growth (SSSG) at 5%.\n*   \u003Cb>Online Segment Update:\u003C\u002Fb> LimeRoad's EBITDA loss was reduced by 57%, but its Net Merchandise Value (NMV) declined by 25% as the company focused on profitability.\n*   \u003Cb>Improved Returns:\u003C\u002Fb> Return on Equity (RoE) improved significantly from 5.9% in FY25 to 14.1% in FY26.",{"company_name":86,"filing_date":149,"filing_source":9,"headline":150,"id":151,"stock_code":48,"summary_text":152},"2026-05-07T20:01:41.816000","FY26 Revenue Soars 62%, But Faces ₹13,125 Lakh Legal Setback","69fca294ec7f5de862c575f6","*   Consolidated revenue from operations grew 62.3% YoY to ₹5,08,842 lakh, driven by a 159% surge in the Steel segment.\n*   The Board has recommended a final dividend of ₹0.50 per share for the financial year 2025-26.\n*   \u003Cb>Key Risk:\u003C\u002Fb> The High Court dismissed the company's petition against a ₹13,125 lakh demand for forestry charges. The company is now appealing to the Supreme Court.\n*   The company demonstrated financial strength by early redeeming Non-Convertible Debentures (NCDs) worth ₹42,300 lakh using internal accruals.\n*   A new Downhill Conveyor System is under development and expected to commence operations in FY 2026-27.",{"company_name":154,"filing_date":155,"filing_source":9,"headline":156,"id":157,"stock_code":158,"summary_text":159},"Hindustan Unilever Ltd","2026-05-07T20:01:41.676000","HUL Posts Strongest Quarterly Growth in 3 Years, Flags Cost Headwinds","69fca2a158d87443453a07fe","HINDZINC","*   \u003Cb>Record Q4 Performance\u003C\u002Fb>: Delivered its highest quarterly growth in 12 quarters, with 7% Underlying Sales Growth (USG) and 6% Underlying Volume Growth (UVG).\n*   \u003Cb>Segment Strength\u003C\u002Fb>: Home Care was the top performer, growing 9% (strongest in 11 quarters), driven by double-digit growth in Fabric Wash and Household Care.\n*   \u003Cb>Shareholder Payout\u003C\u002Fb>: The Board declared a final dividend of ₹22 per share, bringing the total dividend for FY26 to ₹41 per share.\n*   \u003Cb>Future Investment\u003C\u002Fb>: Announced a planned capex of ₹2,000 crores to expand capacity in premium Beauty and Home Care formats.\n*   \u003Cb>Key Risk\u003C\u002Fb>: Management flagged a sharp spike in crude-linked commodity costs due to geopolitical issues, leading to price increases of 2-5% and potentially more to come.",{"company_name":161,"filing_date":162,"filing_source":17,"headline":163,"id":164,"stock_code":165,"summary_text":166},"Cybertech Systems And Software Limited","2026-05-07T20:01:40.803000","Completes ₹40.28 Cr Investment in US Subsidiary","69fca275f35e30561cff962b","CYBERTECH","*   The company has announced the full utilization of funds amounting to ₹ 40,27,72,500 raised via a preferential allotment.\n*   The entire proceeds have been invested into the equity capital of its wholly-owned US subsidiary, CyberTech Systems and Software Inc., USA.\n*   This strategic investment was in line with the objectives approved by shareholders in November 2023.\n*   The funds were fully utilized as of May 07, 2026.",{"company_name":168,"filing_date":169,"filing_source":17,"headline":170,"id":171,"stock_code":172,"summary_text":173},"Manaksia Aluminium Company Limited","2026-05-07T20:01:40.440000","Recommends Final Dividend for FY 2025-26","69fca272c9cbead9b3c585b7","MANAKALUCO","*   The Board has recommended a Final Dividend of Re. 0.05 per equity share for the financial year 2025-26.\n*   This represents a 5% dividend on the face value of Re. 1\u002F- per share.\n*   The dividend is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).\n*   The Record Date and Payment Date will be decided and announced at a future board meeting.",{"company_name":175,"filing_date":176,"filing_source":17,"headline":177,"id":178,"stock_code":179,"summary_text":180},"Aditya Birla Lifestyle Brands Limited","2026-05-07T20:01:40.439000","Board Recommends Final Dividend for FY 2025-26","69fca26cf43b112c8d9214af","ABLBL","*   The Board has recommended a **Final Dividend** of **Rs. 1 per equity share** for the financial year 2025-26.\n*   The **Record Date** to determine shareholder eligibility is **August 7, 2026**.\n*   Payment is subject to shareholder approval at the Annual General Meeting (AGM) scheduled for August 19, 2026.\n*   If approved, the dividend will be paid on or before **September 17, 2026**.",{"company_name":58,"filing_date":182,"filing_source":17,"headline":183,"id":184,"stock_code":62,"summary_text":185},"2026-05-07T20:01:40.391000","Announces Dividend, Strategic Expansion & Key Board Changes","69fca2aabf8f716f13ffa686","*   \u003Cb>Final Dividend:\u003C\u002Fb> The Board recommended a final dividend of ₹7.00 per share for FY 2025-26, subject to shareholder approval.\n*   \u003Cb>Strategic Pivot:\u003C\u002Fb> Approved altering the company's charter to expand into hospitals, digital health, and medical equipment, signaling a major move beyond pure-play diagnostics.\n*   \u003Cb>Board Shake-up:\u003C\u002Fb> Appointed two new directors from parent company API Holdings (PharmEasy) and announced the resignation of two directors. CEO Rahul Guha was re-appointed for another 5-year term.\n*   \u003Cb>Subsidiary Investment:\u003C\u002Fb> Approved an investment of up to ₹5.5 Crores in its wholly-owned subsidiary, Think Health Diagnostics.\n*   \u003Cb>New Auditor:\u003C\u002Fb> Proposed appointing M\u002Fs. Price Waterhouse Chartered Accountants LLP (PwC) as the new Statutory Auditor.",{"company_name":44,"filing_date":187,"filing_source":17,"headline":188,"id":189,"stock_code":48,"summary_text":190},"2026-05-07T20:01:40.314000","FY26 Results: Strong Growth & Debt Reduction Overshadowed by Legal Risk","69fca2a4ecaa861d94922403","*   Consolidated revenue surged 66.8% YoY, driven by exceptional performance in the Steel (+159.1%) and Ferroalloys (+205.2%) segments.\n*   Consolidated EPS grew 40% to ₹13.51 for FY26.\n*   Shareholders were rewarded with a 2:1 bonus issue (Sept 2025) and a recommended final dividend of ₹0.50 per share for FY26.\n*   Strengthened its balance sheet by significantly reducing debt, including an early redemption of NCDs worth ₹42,300 lakh.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The company faces a potential liability of ₹13,125 lakh after an adverse High Court ruling regarding forest lease charges. It plans to appeal to the Supreme Court.",{"company_name":168,"filing_date":192,"filing_source":17,"headline":193,"id":194,"stock_code":172,"summary_text":195},"2026-05-07T20:01:40.064000","Key Auditor Appointments Bolster Governance","69fca273890e096a6fc590a9","*   Manaksia Aluminium has appointed M\u002Fs. S. BHALOTIA & ASSOCIATES as its new Internal Auditor.\n*   The company also appointed M\u002Fs. S. CHHAPARIA & ASSOCIATES as its new Cost Auditor.\n*   Both appointments are effective from May 7, 2026.\n*   These appointments are a positive governance practice, intended to provide shareholders with assurance on the company's financial records and internal controls.",{"company_name":65,"filing_date":197,"filing_source":17,"headline":198,"id":199,"stock_code":69,"summary_text":200},"2026-05-07T20:01:40.048000","Board Recommends Final Dividend of ₹3 Per Share","69fca26babd16353d2ffb085","*   The Board of Directors has recommended a Final Dividend of ₹3 per equity share for the Financial Year 2025-26.\n*   This dividend payment is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).",{"company_name":161,"filing_date":202,"filing_source":17,"headline":203,"id":204,"stock_code":165,"summary_text":205},"2026-05-07T20:01:40.042000","Cybertech Boosts US Subsidiary with $4.34M Capital Injection","69fca27ca157653c663a1219","• CyberTech has invested **US$ 4,344,900** in its wholly-owned US subsidiary, CyberTech Systems & Software Inc. (CSSI), via a cash remittance.\n• The capital contribution is intended to \"facilitate the business\" of the US subsidiary, which specializes in Enterprise Cloud Transformation, SAP, and Esri ArcGIS services.\n• The US subsidiary has shown consistent turnover growth, reaching **$22.40 million** in the 2024-2025 financial year.\n• The investment is classified as a **Related Party Transaction (RPT)** conducted on an \"arm's length basis.\"\n• CyberTech's shareholding in the subsidiary remains unchanged at **100%**.",{"company_name":58,"filing_date":207,"filing_source":17,"headline":208,"id":209,"stock_code":62,"summary_text":210},"2026-05-07T20:01:39.986000","Strategic Pivot, Board Shake-up & Dividend Announced","69fca2950c6b4fb98a922eee","*   **Major Strategic Shift**: The Board approved altering the company's charter (MOA) to expand beyond diagnostics into hospitals, digital health platforms, and manufacturing\u002Ftrading of medical products.\n*   **Dividend Declared**: Recommended a final dividend of ₹7.00 per share for FY 2025-26. The total dividend for the year amounts to ₹9.33 per share (post-bonus adjustment).\n*   **Board Overhaul & Parent Co. Influence**: Two directors resigned and were replaced by two senior executives from the parent company, API Holdings (PharmEasy), indicating a strengthening of the parent's control.\n*   **Subsidiary Investment (Red Flag)**: Approved a ₹5.50 Crore investment into a subsidiary (Think Health Diagnostics) whose turnover has collapsed to just ₹1 Lakh (₹0.01 Crore) in FY26.\n*   **New 'Big Four' Auditor**: Proposed the appointment of M\u002Fs. Price Waterhouse Chartered Accountants LLP (PwC) as the new Statutory Auditors.\n*   **Leadership Continuity**: Re-appointed Mr. Rahul Guha as Chairman, MD & CEO for a further five-year term from May 2027.",{"company_name":212,"filing_date":213,"filing_source":9,"headline":214,"id":215,"stock_code":216,"summary_text":217},"Alivus Life Sciences Ltd","2026-05-07T19:56:40.879000","Board Meeting on May 14 to Consider FY26 Results & Dividend","69fca16a890e096a6fc590a1","ALIVUS","• The Board of Directors will meet on May 14, 2026, to approve the audited financial results for the quarter and year ended March 31, 2026.\n• The Board will also consider and recommend a dividend for the financial year 2025-26.\n• The trading window for designated persons is closed from April 01, 2026, to May 16, 2026.\n• **Please Note**: The company was formerly known as Glenmark Life Sciences Limited.",{"company_name":219,"filing_date":220,"filing_source":9,"headline":221,"id":222,"stock_code":20,"summary_text":223},"Mahanagar Gas Ltd","2026-05-07T19:56:40.825000","Q4 & FY26 Results: Profits Fall Sharply Despite Revenue Growth","69fca19eecaa861d949223ff","\u003Cul>\n    \u003Cli>\u003Cb>Profit Plunge:\u003C\u002Fb> Profit After Tax (PAT) fell sharply by 18.7% YoY for the full year (FY26) and plunged 34.7% QoQ for the fourth quarter.\u003C\u002Fli>\n    \u003Cli>\u003Cb>Margin Squeeze:\u003C\u002Fb> Despite a 13.6% YoY increase in revenue driven by an 8.25% rise in sales volume, profitability was hit hard, signaling a significant squeeze on margins.\u003C\u002Fli>\n    \u003Cli>\u003Cb>Dividend Declared:\u003C\u002Fb> The Board recommended a final dividend of ₹18 per share. This brings the total dividend for the financial year to ₹30 per share.\u003C\u002Fli>\n    \u003Cli>\u003Cb>Red Flag - Legal Risks:\u003C\u002Fb> The company faces significant contingent liabilities of over ₹386 Crore from legal and tax disputes, for which no provisions have been made.\u003C\u002Fli>\n\u003C\u002Ful>",{"company_name":225,"filing_date":226,"filing_source":9,"headline":227,"id":228,"stock_code":179,"summary_text":229},"Aditya Birla Lifestyle Brands Ltd","2026-05-07T19:56:40.773000","Q4 & FY26 Results: Strong Standalone Performance Driven by Reebok and Emerging Brands","69fca190f43b112c8d9214ab","*   **Financials:** Consolidated Revenue grew 12% YoY to ₹2,174 Cr in Q4 and 7% to ₹8,396 Cr for the full year (FY26), with a full-year EBITDA margin of 17.0%.\n*   **Segment Highlights:** The Emerging Business segment showed strong momentum with 18% revenue growth in Q4, driven by Reebok's ~30% YoY growth and Van Heusen Innerwear's continued double-digit LTL growth.\n*   **Strategic Restructuring:** The company has closed its Forever21 (F21) operations, a move that suppressed annual revenue growth but significantly boosted the segment's profitability and margin.\n*   **Network & Debt:** Aggressively expanded its retail footprint with over 300 new stores in FY26 while successfully reducing Net Debt to ₹726 Cr (down from ₹781 Cr).\n*   **Corporate Context:** The results reflect the company's performance as a newly demerged, standalone entity, marking a \"robust start\" according to management.",{"company_name":231,"filing_date":232,"filing_source":9,"headline":233,"id":234,"stock_code":235,"summary_text":236},"Escorts Kubota Ltd","2026-05-07T19:56:40.684000","Q4 & FY26 Earnings Call Audio Recording Published","69fca16cec7f5de862c575ef","ESCORTS","*   The company has published the audio recording of its investor conference call discussing financial results for the quarter and year ended March 31, 2026.\n*   This filing is a procedural update to provide shareholders with a direct weblink to the call's recording, as required by SEBI regulations.\n*   The audio is available on the company's website at: `https:\u002F\u002Fwww.escortskubota.com\u002Finvestors\u002Ffinancials`\n*   Investors should refer to the audio recording for substantive details on performance and outlook, as this document is for notification purposes only.",{"company_name":238,"filing_date":239,"filing_source":9,"headline":240,"id":241,"stock_code":69,"summary_text":242},"CCL Products (India) Ltd","2026-05-07T19:56:40.670000","ESOP Grants and Management Restructuring Announced","69fca17a5236ec998939fa47","*   The company granted 1,61,850 Employee Stock Options (ESOPs) at an exercise price of ₹2 per share (face value).\n*   The list of Senior Management Personnel (SMP) has been redefined and revised to align with the current organizational structure.\n*   The new SMP list includes the CEO, CFO, Company Secretary, CHRO, and Heads of Business Development & Operations.\n*   The filing notes that 6,475 options have lapsed due to employee resignations, a data point on attrition.",{"company_name":244,"filing_date":245,"filing_source":17,"headline":246,"id":247,"stock_code":248,"summary_text":249},"WESTLIFE FOODWORLD LIMITED","2026-05-07T19:56:40.034000","Q4 FY26 Earnings Call Recording Now Public","69fca148f35e30561cff9615","WESTLIFE","*   Westlife Foodworld has published the audio recording of its earnings conference call for the quarter ended March 31, 2026.\n*   This filing is a procedural update to comply with SEBI regulations and does not contain new financial or operational data.\n*   The recording provides stakeholders with direct access to management's discussion and analysis and is available on the company's website.\n*   No red flags or unusual developments were noted in the filing; it represents a standard compliance action.",{"company_name":251,"filing_date":252,"filing_source":17,"headline":253,"id":254,"stock_code":255,"summary_text":256},"Gandhar Oil Refinery (India) Limited","2026-05-07T19:56:40.023000","Receives Favorable Order for ₹22.92 Crore Refund","69fca1405236ec998939fa44","GANDHAR","*   The company has received a favorable order from the Commissioner of Customs (Appeals) sanctioning a refund claim.\n*   The total refund amount is **₹22,92,06,499\u002F- (approx. ₹22.92 Crores)** for the periods 2018-19 and 2019-20.\n*   This is a positive development that the company states will augment its working capital and strengthen its financial position.",{"company_name":258,"filing_date":259,"filing_source":17,"headline":260,"id":261,"stock_code":262,"summary_text":263},"Matrimony.Com Limited","2026-05-07T19:56:39.891000","ESOP Allotment Update: 3,100 New Shares Issued","69fca146ecaa861d949223fd","MATRIMONY","*   The company allotted 3,100 equity shares to employees under its Employee Stock Option Scheme 2014.\n*   Shares were issued at an exercise price of ₹336.40 per share, resulting in a cash inflow of ₹10.43 Lakhs for the company.\n*   The allotment was approved by the Share Allotment Committee on March 25, 2026.\n*   Post-allotment, the total issued share capital has increased to 2,06,73,393 equity shares.",{"company_name":168,"filing_date":265,"filing_source":17,"headline":266,"id":267,"stock_code":172,"summary_text":268},"2026-05-07T19:56:39.858000","FY26 Results: Profit Jumps 25%, but a ₹42 Crore GST Demand Looms","69fca164c9cbead9b3c585ad","*   \u003Cb>Profit After Tax (PAT) grew by 25.04%\u003C\u002Fb> to ₹755.61 Lakhs for the year ended March 31, 2026.\n*   \u003Cb>Revenue from Operations increased by 8.15%\u003C\u002Fb> year-over-year to ₹59,390.67 Lakhs.\n*   The Board has recommended a \u003Cb>Final Dividend of 5%\u003C\u002Fb> (₹0.05 per share), subject to shareholder approval.\n*   Announced international expansion with the incorporation of \u003Cb>new entities in the USA and UAE\u003C\u002Fb>.\n*   \u003Cb>KEY RISK:\u003C\u002Fb> The company faces a contingent liability of over \u003Cb>₹42.68 Crore\u003C\u002Fb> from a GST demand, which has been highlighted by the auditor as an \"Emphasis of Matter\".",{"company_name":58,"filing_date":270,"filing_source":17,"headline":271,"id":272,"stock_code":62,"summary_text":273},"2026-05-07T19:56:39.765000","Announces Dividend, Board Overhaul, and Strategic Expansion","69fca175bf8f716f13ffa67f","*   The Board has recommended a final dividend of ₹ 7.00 per equity share for the financial year 2025-26.\n*   Approved a strategic investment of up to ₹ 5.5 Crores in its wholly-owned subsidiary, Think Health Diagnostics Private Limited.\n*   Announced significant board changes, appointing two senior executives from parent company API Holdings and accepting two resignations, tightening the parent's control.\n*   Proposed a major alteration to its Memorandum of Association (MOA) to broaden its business scope into the wider healthcare and diagnostics ecosystem.\n*   Recommended the appointment of M\u002Fs. Price Waterhouse Chartered Accountants LLP as the new Statutory Auditors, replacing the outgoing auditors.",{"company_name":275,"filing_date":276,"filing_source":17,"headline":277,"id":278,"stock_code":279,"summary_text":280},"Gravita India Limited","2026-05-07T19:56:39.745000","Announces New ₹160 Crore Copper Recycling Plant","69fca14a58d87443453a07f2","GRAVITA","• \u003Cb>Project:\u003C\u002Fb> To set up a new Copper Recycling Plant in Mandvi, Gujarat.\n• \u003Cb>Investment:\u003C\u002Fb> Capital expenditure of approximately ₹160 crore.\n• \u003Cb>Capacity:\u003C\u002Fb> The plant will have an installed capacity of ~29,400 MTPA.\n• \u003Cb>Funding:\u003C\u002Fb> The entire project will be funded through the company's internal accruals.\n• \u003Cb>Timeline:\u003C\u002Fb> Commercial operations are expected to commence within the next 12 months.\n• \u003Cb>Strategic Goal:\u003C\u002Fb> To expand its non-ferrous metal portfolio and meet growing demand for recycled copper.",{"company_name":175,"filing_date":282,"filing_source":17,"headline":283,"id":284,"stock_code":179,"summary_text":285},"2026-05-07T19:56:39.579000","Reports 12% Q4 Revenue Growth & Strong Start as Demerged Entity","69fca16c0c6b4fb98a922ee5","*   Consolidated revenue grew 12% YoY to ₹2,174 Cr in Q4 FY26, marking the second consecutive quarter of double-digit growth.\n*   **Reebok** was a standout performer, delivering ~30% YoY growth in Q4. The **Emerging Business** segment's revenue grew 18% in the quarter.\n*   Profitability improved, with the Emerging Business segment's margin expanding by 370 bps in FY26, driven by the strategic **closure of the Forever21 business**.\n*   Net Debt was reduced from ₹781 Cr in Mar'25 to ₹726 Cr in Mar'26, indicating strong financial management.\n*   **Key Context:** This performance follows a \"seamless demerger,\" with FY26 being the company's first major year as a standalone entity.",{"company_name":287,"filing_date":288,"filing_source":17,"headline":289,"id":290,"stock_code":216,"summary_text":291},"Alivus Life Sciences Limited","2026-05-07T19:56:39.460000","Board Meeting on May 14 to Approve FY26 Results & Consider Dividend","69fca148890e096a6fc5909f","*   A Board of Directors meeting is scheduled for Thursday, May 14, 2026.\n*   The agenda includes approving the audited financial results for the quarter and year ended March 31, 2026.\n*   The Board will also consider and recommend a dividend for the financial year 2025-26.\n*   The trading window is closed for designated persons from April 01, 2026, to May 16, 2026.\n*   The company has changed its name from \"Glenmark Life Sciences Limited\" to \"Alivus Life Sciences Limited\".",{"company_name":293,"filing_date":294,"filing_source":17,"headline":295,"id":296,"stock_code":146,"summary_text":297},"V-Mart Retail Limited","2026-05-07T19:56:39.456000","FY26 Results: 507% PAT Growth & 3:1 Bonus Share Issue","69fca198abd16353d2ffb080","*   \u003Cb>FY26 Financials:\u003C\u002Fb> Revenue from operations grew 16% YoY to ₹37,894 Mn. Adjusted Profit After Tax (PAT) surged 507% YoY to ₹1,250 Mn.\n*   \u003Cb>Profitability:\u003C\u002Fb> Consolidated EBITDA increased by 36% YoY to ₹5,134 Mn, with Return on Equity (RoE) improving from 5.9% to 14.1%.\n*   \u003Cb>Bonus Issue:\u003C\u002Fb> The company issued 3 bonus shares for every 1 fully paid-up equity share held during FY26.\n*   \u003Cb>Operational Growth:\u003C\u002Fb> Added a net of 80 new stores, reaching a total of 577. Same Store Sales Growth (SSSG) stood at 5%.\n*   \u003Cb>Segment Performance:\u003C\u002Fb> While V-Mart and Unlimited segments grew strongly, the online platform LimeRoad saw a 25% YoY decline in Net Merchandise Value (NMV), marking it a key risk area despite reduced losses.",{"company_name":299,"filing_date":300,"filing_source":17,"headline":301,"id":302,"stock_code":235,"summary_text":303},"Escorts Kubota Limited","2026-05-07T19:56:39.412000","Audio Recording of Earnings Call for Q4 & FY26 Now Available","69fca149a157653c663a1209","• The company has provided a weblink to the audio recording of its earnings conference call held on May 07, 2026.\n• This call discusses the financial performance for the quarter and financial year ended March 31, 2026.\n• Investors can access the recording on the company's website to gain insights from management on financial results and outlook.\n• The disclosure enhances transparency for shareholders by providing direct access to the discussion on the company's performance.",{"company_name":305,"filing_date":306,"filing_source":17,"headline":307,"id":308,"stock_code":309,"summary_text":310},"NDL Ventures Limited","2026-05-07T19:51:43.036000","Board Approves Re-appointment of Independent Director","69fca06cbf8f716f13ffa67a","NDLVENTURE","• The Board has re-appointed Mr. Munesh Narinder Khanna as a Non-Executive Independent Director.\n• The re-appointment is effective from 13 May 2026.\n• This action is a standard governance procedure to ensure board continuity and independence.",{"company_name":168,"filing_date":312,"filing_source":17,"headline":313,"id":314,"stock_code":172,"summary_text":315},"2026-05-07T19:51:43.029000","Posts Strong FY26 Results & Recommends Dividend","69fca07e5236ec998939fa40","*   \u003Cb>Profit Growth:\u003C\u002Fb> Full-year Net Profit (PAT) for FY26 grew by 24.98% to ₹755.61 Lakhs. Q4 PAT surged 61.96% year-over-year.\n*   \u003Cb>Revenue Growth:\u003C\u002Fb> Revenue from Operations for FY26 increased by 10.75% to ₹56,390.67 Lakhs.\n*   \u003Cb>Dividend Declared:\u003C\u002Fb> The Board recommended a Final Dividend of ₹0.05 per share (5%) for FY 2025-26, subject to shareholder approval.\n*   \u003Cb>Major Risk Highlighted:\u003C\u002Fb> The company faces a contingent liability from a GST demand of ₹42.68 Crore plus interest. Management is contesting the demand and believes no provision is required.\n*   \u003Cb>International Expansion:\u003C\u002Fb> Incorporated two new subsidiaries, one in the USA and one in the UAE, for future growth.",{"company_name":175,"filing_date":317,"filing_source":17,"headline":318,"id":319,"stock_code":179,"summary_text":320},"2026-05-07T19:51:42.927000","Q4 Results: Revenue Jumps 12%, Emerging Brands Shine","69fca073a157653c663a1205","*   Consolidated revenue grew 12% YoY to ₹2,174 Cr for Q4 FY26, driven by strong performance across segments.\n*   The 'Emerging Business' segment (Reebok, American Eagle) was the top performer, with 18% YoY revenue growth and a significant 420 bps margin expansion.\n*   Net debt was reduced to ₹726 Cr from ₹781 Cr over the last year, strengthening the balance sheet.\n*   Full-year (FY26) normalized Profit After Tax (PAT) surged by 61% YoY to ₹209 Cr.\n*   \u003Cb>Important Note:\u003C\u002Fb> The company appears to be a new entity (incorporated in 2024), likely from a demerger. Historical financials should be viewed as pro-forma.",{"company_name":72,"filing_date":322,"filing_source":17,"headline":323,"id":324,"stock_code":76,"summary_text":325},"2026-05-07T19:51:42.813000","Board Meeting Highlights: Final Dividend, Acquisition, and ESOPs Announced","69fca06af35e30561cff9611","*   The Board has recommended a final dividend of **₹2 per equity share** for the financial year ended March 31, 2026, subject to shareholder approval.\n*   Approved the acquisition of the MRI, EEG, and NCV Services Business from its wholly-owned subsidiary, Medinova Millennium MRI Services LLP, for a cash consideration of approximately **₹4.20 Crore**.\n*   Dr. D Nageshwar Reddy, an Independent Director, will not seek re-appointment for a second term upon the conclusion of his current term on May 25, 2026.\n*   The Board approved the grant of **1,79,500 Employee Stock Options (ESOPs)** to eligible employees.\n*   Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026, were approved.",{"company_name":327,"filing_date":328,"filing_source":17,"headline":329,"id":330,"stock_code":331,"summary_text":332},"Dev Information Technology Limited","2026-05-07T19:51:42.811000","Wins ₹2.79 Crore Order from GIFT City","69fca0560c6b4fb98a922edb","DEVIT","*   **New Order:** The company has secured a new contract from Gujarat International Finance Tec-City (GIFT).\n*   **Order Value:** The contract is valued at \u003Cb>₹ 2.79 Crores\u003C\u002Fb>.\n*   **Project Scope:** The project involves creating a centralized technology platform for real-time visualization, project monitoring, and citizen engagement.\n*   **Duration:** The contract has a duration of 2 years.",{"company_name":334,"filing_date":335,"filing_source":17,"headline":336,"id":337,"stock_code":338,"summary_text":339},"Damodar Industries Limited","2026-05-07T19:51:42.715000","Board to Meet on May 15 to Approve Annual Financials","69fca05dc9cbead9b3c585a8","DAMODARIND","• A Board Meeting has been scheduled for **May 15, 2026**.\n• The primary agenda is to consider and approve the Audited Standalone Financial Results for the financial year ended March 31, 2026.\n• No other significant corporate actions like dividends have been mentioned in this intimation.",{"company_name":341,"filing_date":342,"filing_source":17,"headline":343,"id":344,"stock_code":345,"summary_text":346},"Pidilite Industries Limited","2026-05-07T19:51:42.694000","Recommends Final Dividend of ₹11.50 Per Share","69fca04e58d87443453a07e7","PIDILITIND","*   The Board of Directors has recommended a Final Dividend of ₹11.50 per equity share.\n*   This dividend is subject to shareholder approval at the upcoming Annual General Meeting (AGM).\n*   The Record Date and the date of the AGM will be announced in due course.",{"company_name":293,"filing_date":348,"filing_source":17,"headline":349,"id":350,"stock_code":146,"summary_text":351},"2026-05-07T19:51:42.589000","Key Dates for AGM & Final Dividend Confirmed","69fca04dec7f5de862c575e1","• The 24th Annual General Meeting (AGM) will be held on \u003Cb>Thursday, July 30, 2026\u003C\u002Fb>.\n• The Board has recommended a final dividend for FY 2025-26, which is subject to shareholder approval at the AGM.\n• The Record Date to determine eligibility for the final dividend is set for \u003Cb>Friday, July 17, 2026\u003C\u002Fb>.\n• Note: The specific dividend amount per share has not been disclosed in this filing.",{"company_name":168,"filing_date":353,"filing_source":17,"headline":354,"id":355,"stock_code":172,"summary_text":356},"2026-05-07T19:51:42.572000","FY26 Results: Profit Soars & Dividend Recommended, but a Major Risk Flagged","69fca05d890e096a6fc59096","*   \u003Cb>Strong Financials:\u003C\u002Fb> Net Profit for FY26 grew by 25% to ₹7.56 Cr. For Q4 FY26, Net Profit surged by 62% YoY to ₹3.24 Cr.\n*   \u003Cb>Dividend:\u003C\u002Fb> The Board has recommended a final dividend of Re 0.05 per equity share for the financial year 2025-26, subject to shareholder approval.\n*   \u003Cb>Global Expansion:\u003C\u002Fb> The company has incorporated two new subsidiaries in the USA (\"Manaksia Aluminium Inc.\") and UAE (\"Metal Star Celling Panel FZE\") as part of its international strategy.\n*   \u003Cb>Red Flag - Major Risk:\u003C\u002Fb> Auditors have highlighted a significant contingent liability of \u003Cb>₹42.68 Crore plus interest\u003C\u002Fb> from a GST demand order. The company has contested this but has not made any provision for it in its financials.\n*   \u003Cb>Unusual Reporting:\u003C\u002Fb> Consolidated financial statements were not prepared for FY26, as the company stated that share application money for its new overseas subsidiaries is yet to be deposited.",{"company_name":358,"filing_date":359,"filing_source":17,"headline":360,"id":361,"stock_code":362,"summary_text":363},"Vesuvius India Limited","2026-05-07T19:51:42.523000","Board Meeting Update: No Interim Dividend Declared","69fca02458d87443453a07e5","VESUVIUS","*   The Board of Directors met on May 7, 2026, to consider the declaration of an interim dividend.\n*   Following the meeting, the Board has decided **not** to declare any interim dividend.\n*   This is a material development for shareholders, as it may signal a decision to conserve cash or reflect current business conditions.",{"company_name":365,"filing_date":366,"filing_source":17,"headline":367,"id":368,"stock_code":369,"summary_text":370},"Kody Technolab Limited","2026-05-07T19:51:42.510000","Appoints New CEO, COO, and CMO to Spearhead Growth","69fca028f35e30561cff960f","KODYTECH","*   Mr. Sanjaykumar Kidecha has been promoted from Chief Operating Officer (COO) to Chief Executive Officer (CEO), ensuring leadership continuity.\n*   The company appointed two new senior leaders: Mr. Nirav Panchal as COO and Mr. Savant Fernandez as CMO.\n*   These appointments signal a reinforced strategic focus on the robotics division, leveraging the new leaders' experience in robotics rollouts and marketing.\n*   The former COO's resignation was a procedural step for his promotion to CEO and is viewed as a positive development, not a red flag.",{"company_name":372,"filing_date":373,"filing_source":9,"headline":374,"id":375,"stock_code":376,"summary_text":377},"Raymond Lifestyle Ltd","2026-05-07T19:51:41.676000","Q4 & FY26 Investor Call Recording Now Available","69fca025c9cbead9b3c585a6","RAYMONDLSL","*   Raymond Lifestyle has published the audio recording of its investor conference call held on May 7, 2026.\n*   The call discussed the financial performance for the fourth quarter and the full year ended March 31, 2026.\n*   This filing serves as a compliance update, informing stock exchanges and investors that the recording is now public.\n*   Stakeholders can access the recording on the company's website to hear management's discussion on performance and outlook.",{"company_name":379,"filing_date":380,"filing_source":9,"headline":381,"id":382,"stock_code":345,"summary_text":383},"Pidilite Industries Ltd","2026-05-07T19:51:41.658000","FY26 Results: Strong Growth, Declares Dividend & Highlights 1:1 Bonus","69fca056abd16353d2ffb06f","*   \u003Cb>Strong Performance:\u003C\u002Fb> Consolidated revenue grew 10.4% YoY to ₹14,601 Cr. Profit Before Tax stood at ₹3,320 Cr, driven by the core Consumer & Bazaar segment which grew 11.4%.\n*   \u003Cb>Shareholder Rewards:\u003C\u002Fb> The Board recommended a Final Dividend of ₹11.50 per share. This follows a recently completed 1:1 bonus issue in Sep 2025.\n*   \u003Cb>New Costs:\u003C\u002Fb> Recognized new expenses of over ₹80 Cr in FY26 due to the implementation of new Labour Codes.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The company reported an exceptional loss of ₹13.71 Cr from impairment on investments in associate companies, a recurring issue from the previous year.",{"company_name":92,"filing_date":385,"filing_source":9,"headline":386,"id":387,"stock_code":76,"summary_text":388},"2026-05-07T19:51:41.566000","Board Declares Dividend, Approves Acquisition & Notes Director's Exit","69fca040bf8f716f13ffa678","• \u003Cb>Final Dividend:\u003C\u002Fb> The Board recommended a final dividend of ₹2 per share for the financial year ended March 31, 2026, subject to shareholder approval.\n• \u003Cb>Internal Acquisition:\u003C\u002Fb> Approved the acquisition of the MRI, EEG, and NCV services business from its wholly-owned subsidiary for a cash consideration of approximately ₹4.20 Crores.\n• \u003Cb>Board Update:\u003C\u002Fb> Dr. D Nageshwar Reddy, an Independent Director, will not be seeking re-appointment for a second term and will cease to be a director from May 25, 2026.\n• \u003Cb>ESOP Grant:\u003C\u002Fb> Approved the grant of 1,79,500 Employee Stock Options (ESOPs) to eligible employees at an exercise price of ₹784 per option.",{"company_name":390,"filing_date":391,"filing_source":9,"headline":392,"id":393,"stock_code":62,"summary_text":394},"Thyrocare Technologies Ltd","2026-05-07T19:51:41.422000","Thyrocare Signals Major Strategic Shift, Appoints PwC & Declares Dividend","69fca03f5236ec998939fa3e","• The Board has recommended a final dividend of ₹7.00 per share for FY 2025-26.\n• Approved a major alteration of its business scope (MOA) to expand from a diagnostics-only company to an integrated healthcare player.\n• Proposed the appointment of M\u002Fs. Price Waterhouse Chartered Accountants LLP (PwC) as the new Statutory Auditors.\n• Strengthened parent company (API Holdings\u002FPharmEasy) influence by appointing two of its senior executives to Thyrocare's Board.\n• 🚩 Red Flag: Approved a ₹5.50 crore investment into subsidiary 'Think Health Diagnostics', even as its turnover plummeted to just ₹0.01 crore in FY26 (from ₹3.35 crore in FY24).",{"company_name":142,"filing_date":396,"filing_source":9,"headline":397,"id":398,"stock_code":146,"summary_text":399},"2026-05-07T19:51:41.358000","Announces 24th AGM and Record Date for Final Dividend","69fca0250c6b4fb98a922ed9","• The 24th Annual General Meeting (AGM) is scheduled for July 30, 2026.\n• The Board has recommended a final dividend for the financial year ended March 31, 2026.\n• The Record Date to determine eligibility for the dividend is set for July 17, 2026.\n• The dividend payment is subject to shareholder approval at the upcoming AGM.",{"company_name":225,"filing_date":401,"filing_source":9,"headline":402,"id":403,"stock_code":179,"summary_text":404},"2026-05-07T19:51:41.333000","Posts Strong FY26 Results with 61% Profit Surge","69fca031a157653c663a1203","*   Full-year (FY26) Normalized Profit After Tax (PAT) surged 61% to ₹209 Cr.\n*   FY26 revenue grew 7% to ₹8,396 Cr, with Q4 revenue up 12% year-over-year.\n*   The \"Emerging Business\" segment was the top performer, with 18% YoY revenue growth in Q4 and a significant 420 bps margin expansion.\n*   Net debt was successfully reduced to ₹726 Cr from ₹781 Cr, strengthening the balance sheet.\n*   The company expanded its retail footprint with over 300 gross store additions during the year.",{"company_name":390,"filing_date":406,"filing_source":9,"headline":407,"id":408,"stock_code":62,"summary_text":409},"2026-05-07T19:51:41.068000","Strategic Overhaul & Leadership Changes Announced","69fca040ecaa861d949223dd","*   The Board recommended a final dividend of ₹7.00 per share, bringing the total for FY26 to ₹9.33 per share (post-bonus adjustment).\n*   A major strategic expansion is planned to broaden the company's scope beyond diagnostics into hospitals, digital health, and medical devices, pending shareholder approval.\n*   Mr. Rahul Guha was re-appointed as MD & CEO. Two senior executives from parent company API Holdings (PharmEasy) will join the Board, signaling tighter integration.\n*   The Board proposed appointing Price Waterhouse Chartered Accountants LLP (PwC) as the new Statutory Auditors, replacing the retiring auditors.",{"company_name":411,"filing_date":412,"filing_source":9,"headline":413,"id":414,"stock_code":279,"summary_text":415},"Gravita India Ltd","2026-05-07T19:51:41.028000","Announces New Copper Recycling Plant in Gujarat","69fca024ec7f5de862c575df","*   Plans to establish a new Copper Recycling plant in Mandvi, Gujarat, with a capacity of ~29,400 MTPA.\n*   The total capital expenditure for the project is approximately ₹160 crore.\n*   The entire investment will be funded through the company's internal accruals.\n*   This strategic initiative aims to expand the company's non-ferrous metal recycling portfolio.\n*   Commercial operations are expected to commence within the next 12 months.",{"company_name":417,"filing_date":418,"filing_source":9,"headline":419,"id":420,"stock_code":421,"summary_text":422},"Hindustan Construction Company Ltd","2026-05-07T19:51:41.025000","Investor & Analyst Meet Scheduled","69fca01b890e096a6fc59094","HCC","*   **Event:** The company has scheduled a meeting with analysts and institutional investors.\n*   **Date & Time:** Thursday, May 14, 2026, at 6:00 p.m.\n*   **Format:** The meeting will be held virtually.\n*   **Context:** This is a routine compliance filing under SEBI regulations. No other material information was disclosed.",{"company_name":424,"filing_date":425,"filing_source":9,"headline":426,"id":427,"stock_code":428,"summary_text":429},"CyberTech Systems and Software Ltd","2026-05-07T19:51:41.010000","Invests $4.34M in US Subsidiary for Growth","69fca033f43b112c8d9214a1","532173","*   CyberTech has invested US$ 4,344,900 in its wholly-owned US subsidiary, CyberTech Systems & Software Inc. (CSSI).\n*   The investment is a capital contribution to facilitate the business of the US subsidiary, which has shown consistent year-over-year revenue growth, reaching $22.40 million in the latest period.\n*   This is classified as a Related Party Transaction (RPT) conducted on an \"arm's length basis\".\n*   The company's shareholding in the subsidiary remains unchanged at 100%.",{"company_name":431,"filing_date":432,"filing_source":9,"headline":433,"id":434,"stock_code":435,"summary_text":436},"Stovec Industries Ltd","2026-05-07T19:46:44.769000","Q1 Profit Plummets 40% as Core Textile Segment Falters","69fc9faff35e30561cff960b","504959","*   Profit Before Tax (PBT) for Q1 2026 fell sharply by 40.4% year-over-year to ₹20.58 million, with Profit After Tax (PAT) down 35.5%.\n*   The company's core and largest segment, Textile Machinery & Consumables, saw its revenue decline by 6.9% and its profit (PBIT) drop by 20.1%.\n*   While the smaller Graphics Consumables segment grew revenue by 57.5%, it was insufficient to offset the decline in the main business.\n*   Basic Earnings Per Share (EPS) for the quarter fell to ₹7.96 from ₹12.35 in the corresponding quarter of the previous year.\n*   **Red Flag:** The sharp YoY decline in profitability and the negative performance of the core business, which constitutes over 93% of revenue, is a major concern.",{"company_name":379,"filing_date":438,"filing_source":9,"headline":439,"id":440,"stock_code":345,"summary_text":441},"2026-05-07T19:46:44.491000","FY26 Results: Strong Growth, 1:1 Bonus & High Dividend Payout","69fc9fc3bf8f716f13ffa675","*   Consolidated revenue grew 10.4% to ₹14,845 Cr for FY26, driven by strong performance in the core Consumer & Bazaar segment.\n*   The company issued 1:1 bonus shares in September 2025, doubling the paid-up share capital.\n*   The Board has recommended a final dividend of ₹11.50 per share, following a special interim dividend of ₹10 per share paid earlier in the year.\n*   A key risk noted is the recurring impairment loss on investments in associate companies, with a charge of ₹13.71 Cr in FY26.\n*   Statutory auditors issued an unmodified (clean) opinion on the financial results.",{"company_name":390,"filing_date":443,"filing_source":9,"headline":444,"id":445,"stock_code":62,"summary_text":446},"2026-05-07T19:46:44.158000","Board Approves Strategic Pivot, Dividend, and Key Management Changes","69fc9f99890e096a6fc5908f","*   The Board approved altering the company's charter to expand from a diagnostics provider into an integrated healthcare player, aligning with parent company PharmEasy's strategy.\n*   Two senior executives from parent company API Holdings (PharmEasy) were appointed to the board, solidifying its influence following two resignations.\n*   A final dividend of ₹7.00 per share for FY26 has been recommended, bringing the total dividend for the year to ₹9.33 per share (post-bonus).\n*   An investment of ₹5.50 Crore was approved for its subsidiary, Think Health Diagnostics, despite the subsidiary's turnover dropping from ₹3.35 Cr to ₹0.01 Cr over the past two years.",{"company_name":448,"filing_date":449,"filing_source":9,"headline":450,"id":451,"stock_code":452,"summary_text":453},"Union Bank of India","2026-05-07T19:46:44.154000","Schedules Investor Meeting with Aditya Birla Sun Life AMC","69fc9f725236ec998939fa34","UNIONBANK","*   The bank will hold a one-to-one, in-person meeting with analysts\u002Finvestors.\n*   The meeting is scheduled with Aditya Birla Sun Life AMC Limited.\n*   \u003Cb>Date & Location:\u003C\u002Fb> May 12, 2026, at the bank's Central office in Mumbai.\n*   Union Bank has confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during the interaction.",{"company_name":411,"filing_date":455,"filing_source":9,"headline":456,"id":457,"stock_code":279,"summary_text":458},"2026-05-07T19:46:44.128000","Completes Utilization of ₹1000 Cr QIP Proceeds","69fc9f87abd16353d2ffb069","*   The company has fully utilized the entire gross proceeds of ₹1000 Crore from its Qualified Institutions Placement (QIP) as of March 31, 2026.\n*   Funds were deployed as planned: ₹530 Cr for debt repayment, ₹250 Cr for working capital, and the remainder for general corporate purposes and issue expenses.\n*   Monitoring agency ICRA confirmed the utilization was fully in line with the stated objectives, reporting \"No deviation\".\n*   The deployment strengthens the company's balance sheet through deleveraging and supports operational growth.",{"company_name":460,"filing_date":461,"filing_source":9,"headline":462,"id":463,"stock_code":464,"summary_text":465},"Odyssey Technologies Ltd","2026-05-07T19:46:43.880000","Declares ₹1 Dividend Amidst Flat Revenue & Falling Profits","69fc9fbbc9cbead9b3c585a3","530175","*   **Profit & Revenue:** Profit After Tax (PAT) for FY26 declined by 7.11% to ₹402.33 lakhs, while revenue from operations remained flat (+0.16%).\n*   **Dividend Declared:** The Board has recommended a final dividend of ₹1 per equity share for the financial year 2025-26.\n*   **Strong Balance Sheet:** The company remains debt-free with a strong cash position of ₹4,332.55 lakhs, an increase of 13.15% year-over-year.\n*   **Strategic Focus:** The new 'xorkee' product line contributed 8% to revenue, with the company continuing heavy R&D investment (₹978.25 lakhs) to drive future growth.\n*   **Management Continuity:** Shareholders approved the re-appointment of the Chairman & MD and the Whole-time Director & CFO for three-year terms.",{"company_name":92,"filing_date":467,"filing_source":9,"headline":468,"id":469,"stock_code":76,"summary_text":470},"2026-05-07T19:46:43.616000","Dividend Declared, Business Acquisition & Board Update","69fc9f81ec7f5de862c575d1","*   The Board has recommended a final dividend of ₹2 per equity share for FY26, subject to shareholder approval.\n*   Approved the acquisition of the MRI, EEG, and NCV services business from its wholly-owned subsidiary, Medinova Millennium MRI Services LLP, for a cash consideration of approximately ₹4.20 Crore.\n*   Independent Director Dr. D Nageshwar Reddy will not be seeking re-appointment for a second term upon its conclusion on May 25, 2026.\n*   Approved the grant of 1,79,500 Employee Stock Options (ESOPs) at an exercise price of ₹784 per option.\n*   The Board approved the Audited Financial Results for the quarter and year ended March 31, 2026.",{"company_name":472,"filing_date":473,"filing_source":9,"headline":474,"id":475,"stock_code":476,"summary_text":477},"G M Polyplast Ltd","2026-05-07T19:46:43.594000","Announces Board Meeting for FY26 Financial Results","69fc9f6af35e30561cff9609","543239","• The Board of Directors will meet on Saturday, May 16, 2026, at 11:00 A.M.\n• The primary agenda is to consider and approve the Audited Financial Results for the financial year ended March 31, 2026.\n• The Trading Window for insiders has been closed until the financial results are made public, as per compliance requirements.",{"company_name":390,"filing_date":479,"filing_source":9,"headline":480,"id":481,"stock_code":62,"summary_text":482},"2026-05-07T19:46:43.533000","Major Strategic Pivot, Board Overhaul, and Dividend Declared","69fc9f79ecaa861d949223c1","*   **Dividend:** Recommended a final dividend of ₹7.00 per share for FY 2025-26.\n*   **Strategic Pivot:** Approved a major change to its business scope, aiming to expand from diagnostics into an integrated healthcare ecosystem (hospitals, digital platforms, medical devices).\n*   **Board Shake-up:** Two directors resigned, while two senior executives from parent company API Holdings (PharmEasy) were appointed, indicating stronger parent company influence.\n*   **\"Red Flag\" Investment:** Approved a ₹5.50 crore investment into its subsidiary, Think Health Diagnostics, despite its turnover plummeting from ₹3.35 crore to just ₹0.01 crore in two years.\n*   **Auditor Upgrade:** Proposed appointing PwC (a Big Four firm) as the new Statutory Auditors.",{"company_name":225,"filing_date":484,"filing_source":9,"headline":485,"id":486,"stock_code":179,"summary_text":487},"2026-05-07T19:46:43.267000","Announces Record Date for Final Dividend","69fc9f6b0c6b4fb98a922eb6","*   **Final Dividend Recommended**: ₹ 0.50 per equity share for the financial year ending March 31, 2026.\n*   **Record Date**: Friday, August 7, 2026, has been set to determine shareholder eligibility.\n*   **Payment Date**: The dividend will be paid on or after Thursday, September 17, 2026.\n*   **Important Note**: The dividend payment is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).",{"company_name":424,"filing_date":489,"filing_source":9,"headline":490,"id":491,"stock_code":428,"summary_text":492},"2026-05-07T19:46:42.986000","Deploys ₹40.28 Cr into US Subsidiary","69fc9f5ebf8f716f13ffa673","*   The company has fully utilized the ₹ 40.28 Crores raised from a preferential allotment for which funds were received on December 04, 2023.\n*   The entire amount has been invested into the equity capital of its wholly-owned US subsidiary, CyberTech Systems and Software Inc.\n*   This investment aligns with the objectives approved by shareholders in November 2023, strengthening the company's US operations.\n*   The company confirmed there was no deviation from the proposed use of funds.",{"company_name":411,"filing_date":494,"filing_source":9,"headline":495,"id":496,"stock_code":279,"summary_text":497},"2026-05-07T19:46:42.956000","Acquires RMIL for ₹562 Cr, Posts Q4 & FY26 Results","69fc9f80a157653c663a11f9","*   **Major Acquisition:** Acquired a 99.44% stake in Rashtriya Metal Industries (RMIL) for ₹561.84 crore, marking a strategic entry into the copper recycling segment.\n*   **Q4 Performance:** Revenue grew 13% YoY to ₹1,173 Crores, but Profit After Tax (PAT) declined 3% YoY to ₹91.88 Crores, suggesting margin pressure.\n*   **Full-Year Performance:** For FY26, the company achieved 10% YoY revenue growth and strong 21% YoY PAT growth.\n*   **Segment Weakness:** The Aluminium segment experienced a significant 29.6% YoY decline in sales volume for Q4, acting as a drag on overall performance.\n*   **Strategic Milestones:** Commissioned a new 6,000 MTPA lithium-ion battery recycling plant and expanded lead recycling capacity.\n*   **Future Outlook:** Management guided for ~20-25% volume CAGR and ~30-35% profitability growth as part of its \"VISION 2030\".",{"company_name":499,"filing_date":500,"filing_source":9,"headline":501,"id":502,"stock_code":255,"summary_text":503},"Gandhar Oil Refinery (India) Ltd","2026-05-07T19:46:42.929000","Secures ₹22.92 Crore Refund from Customs Authority","69fc9f4e890e096a6fc5908d","*   The company has received a favorable order from the Commissioner of Customs (Appeals) sanctioning a refund claim of **₹22,92,06,499\u002F-**.\n*   This order pertains to an appeal for a refund filed by the company for the periods 2018-19 and 2019-20.\n*   The company states this refund will augment its working capital, indicating a positive impact on liquidity and financial health.",{"company_name":390,"filing_date":505,"filing_source":9,"headline":506,"id":507,"stock_code":62,"summary_text":508},"2026-05-07T19:46:42.817000","Board Overhaul, Strategic Pivot, and Dividend Declared","69fc9f7158d87443453a07d6","*   The Board recommended a final dividend of ₹7.00 per share for FY26.\n*   Major board reshuffle: Two directors resigned and were replaced by two senior executives from the parent company, API Holdings, indicating tighter control. CEO Rahul Guha was re-appointed.\n*   Proposed change of Statutory Auditor to a 'Big Four' firm, M\u002Fs. Price Waterhouse Chartered Accountants LLP (PwC).\n*   Approved a significant alteration of the company's main objectives (MOA) to expand from a diagnostics player into an integrated healthcare ecosystem provider.\n*   Approved a ₹5.50 Crore investment into its subsidiary, Think Health Diagnostics, despite its turnover plummeting from ₹3.35 Crores to ₹0.01 Crores in two years.",{"company_name":431,"filing_date":510,"filing_source":9,"headline":511,"id":512,"stock_code":435,"summary_text":513},"2026-05-07T19:46:42.473000","Q1 Profit Jumps 914% QoQ, But Revenue Declines","69fc9f6ff43b112c8d921481","*   Profit After Tax (PAT) surged 914% quarter-on-quarter (QoQ) to ₹16.63 million, while Total Income fell 9.56% to ₹474.07 million.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The profit increase was not driven by sales but by an accounting change related to inventory build-up, masking underlying operational weakness.\n*   The core 'Textile Machinery' segment, representing ~95% of business, saw revenue decline by 9.9% QoQ and 6.9% year-on-year (YoY).\n*   The smaller 'Graphics Consumables' segment performed strongly, with revenue growing 57.5% YoY, but its contribution is limited due to its size.",{"company_name":515,"filing_date":516,"filing_source":9,"headline":517,"id":518,"stock_code":262,"summary_text":519},"Matrimony.com Ltd","2026-05-07T19:46:42.469000","Allots 3,100 Equity Shares to Employees Under ESOP","69fc9f38f35e30561cff9607","*   The company allotted 3,100 new equity shares to employees under its Employee Stock Option Scheme 2014.\n*   The shares were issued at an exercise price of ₹336.40 each.\n*   Post-allotment, the total number of issued shares has increased to 2,06,73,393.\n*   The total issued share capital now stands at ₹10,33,66,965.",{"company_name":521,"filing_date":522,"filing_source":9,"headline":523,"id":524,"stock_code":362,"summary_text":525},"Vesuvius India Ltd","2026-05-07T19:46:42.255000","Updates Key Personnel for Regulatory Disclosures","69fc9f330c6b4fb98a922eb4","*   The company has provided updated contact details for its Key Managerial Personnel (KMPs) in compliance with SEBI regulations.\n*   These KMPs are authorized to determine the materiality of events and make necessary disclosures to the stock exchanges.\n*   The designated personnel are Mr. Mohinder Pradip Singh Rajput (Managing Director) and Mr. Neeraj Jumrani (Chief Financial Officer).\n*   This is a routine governance and compliance filing, with no new material information or red flags disclosed.",{"company_name":527,"filing_date":528,"filing_source":9,"headline":529,"id":530,"stock_code":531,"summary_text":532},"Laxmi India Finance Ltd","2026-05-07T19:46:42.203000","Q4 & FY26 Results Conference Call Announced","69fc9f465236ec998939fa32","LAXMIINDIA","• The company will host its \"Q4 FY26 Earnings Conference Call\" to discuss financial performance for the quarter and year ended March 31, 2026.\n• \u003Cb>When:\u003C\u002Fb> Thursday, May 14, 2026, at 12:30 PM IST.\n• \u003Cb>Who:\u003C\u002Fb> The call will be led by senior management, including the Managing Director (Mr. Deepak Baid) and Chief Financial Officer (Mr. Gopal Krishan Sain).\n• \u003Cb>Important Note:\u003C\u002Fb> This filing is a routine notification for the upcoming meeting. The actual financial results and management outlook will be shared during the conference call.",{"company_name":534,"filing_date":535,"filing_source":17,"headline":536,"id":537,"stock_code":538,"summary_text":539},"EMA Partners India Limited","2026-05-07T19:46:41.956000","Correction Issued for Share Buyback Offer","69fc9f3fec7f5de862c575cf","EMAPARTNER","*   The company has issued a corrigendum (correction) for its ongoing share buyback offer of **₹725 Lakhs** at **₹100 per share**.\n*   \u003Cb>Key Financial Correction\u003C\u002Fb>: The Debt-Equity Ratio for FY24 has been changed to **0.22** from the previously stated 0.14 in the offer document.\n*   \u003Cb>Revised Entitlement\u003C\u002Fb>: The number of shares shareholders are entitled to tender in the buyback has been revised for both small and general categories.\n*   \u003Cb>New Risk Disclosed\u003C\u002Fb>: Shareholders may be left with illiquid \"odd lots\" (parcels of shares smaller than the market lot of 1,000) post-buyback.\n*   \u003Cb>Red Flag\u003C\u002Fb>: The need to correct a fundamental financial ratio in a critical offer document raises concerns about the company's internal controls and verification processes.",{"company_name":7,"filing_date":541,"filing_source":9,"headline":542,"id":543,"stock_code":12,"summary_text":544},"2026-05-07T19:46:41.859000","FY26 Results: Revenue Grows 9.4%, but Profits Plunge","69fc9f36ecaa861d949223bf","*   \u003Cb>Revenue Growth:\u003C\u002Fb> Revenue from operations grew 9.4% YoY to ₹604 Cr for the full financial year 2026.\n*   \u003Cb>Profitability Decline:\u003C\u002Fb> Profit After Tax (PAT) fell by 41.2% to ₹3.3 Cr. The company reported a Profit Before Tax (PBT) loss of ₹2.6 Cr, driven by a ₹2.7 Cr exceptional charge related to new labour codes.\n*   \u003Cb>Segment Performance:\u003C\u002Fb> The Trading & Distribution segment was the star performer with 22.5% revenue growth. The Transportation segment declined 11.3% due to a strategic shift to a higher-margin 5PL model.\n*   \u003Cb>Capacity Expansion:\u003C\u002Fb> The company added ~17,000 pallet positions in FY26 and has another 13,000 under development, continuing its expansion roadmap.",{"company_name":390,"filing_date":546,"filing_source":9,"headline":547,"id":548,"stock_code":62,"summary_text":549},"2026-05-07T19:46:41.741000","Announces Major Strategic Shift, Board Overhaul & Dividend","69fc9f44abd16353d2ffb067","*   **Strategic Pivot:** Proposes a major alteration of its Memorandum of Association to expand beyond diagnostics into hospitals, digital health platforms, and medical equipment manufacturing.\n*   **Board Overhaul:** Appointed two senior executives from parent company API Holdings (PharmEasy) as new directors, following two resignations. The Chairman, MD & CEO was also re-appointed for a 5-year term.\n*   **Dividend Declared:** Recommended a final dividend of ₹7.00 per share. The total dividend for FY 2025-26 aggregates to ₹9.33 per share (post-bonus adjustment).\n*   **Auditor Change:** Proposed the appointment of M\u002Fs. Price Waterhouse Chartered Accountants LLP as the new Statutory Auditors.\n*   **Red Flag:** Approved a ₹5.50 Crore investment into its subsidiary, Think Health Diagnostics, despite the subsidiary's turnover collapsing to just ₹0.01 Crores in FY26 from ₹3.35 Crores two years prior.",{"company_name":460,"filing_date":551,"filing_source":9,"headline":552,"id":553,"stock_code":464,"summary_text":554},"2026-05-07T19:46:41.666000","Announces 36th AGM & Annual Report for FY 2025-26","69fc9f2ba157653c663a11f7","• The 36th Annual General Meeting (AGM) will be held virtually via Video Conference on Wednesday, June 3, 2026, at 3:00 PM (IST).\n• The Annual Report for the Financial Year 2025-26 has been released and is being disseminated electronically.\n• The report and AGM notice will be sent to shareholders whose email addresses were registered as of the record date, May 6, 2026.\n• Shareholders are urged to update their email addresses and KYC details with their Depository Participant or the company's Registrar (Cameo Corporate Services Limited).",{"company_name":358,"filing_date":556,"filing_source":17,"headline":557,"id":558,"stock_code":362,"summary_text":559},"2026-05-07T19:46:40.615000","Updates Contact Details for Key Personnel","69fc9f2358d87443453a07d4","*   The company has disclosed updated contact details for its Key Managerial Personnel (KMPs) authorized for making disclosures to stock exchanges.\n*   This filing is in compliance with Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.\n*   The authorized personnel are Mr. Mohinder Pradip Singh Rajput (Managing Director) and Mr. Neeraj Jumrani (Chief Financial Officer).",{"company_name":287,"filing_date":561,"filing_source":17,"headline":562,"id":563,"stock_code":216,"summary_text":564},"2026-05-07T19:46:40.608000","Trading Window Closed Ahead of Financial Results","69fc9f18f43b112c8d92147f","*   The company has closed its trading window for designated persons and their immediate relatives as per insider trading regulations.\n*   This is a standard compliance measure in preparation for the upcoming declaration of financial results.\n*   The trading window will remain closed from April 1, 2026, to May 16, 2026, and will reopen on May 17, 2026.",{"company_name":275,"filing_date":566,"filing_source":17,"headline":567,"id":568,"stock_code":279,"summary_text":569},"2026-05-07T19:46:40.594000","₹1,000 Crore QIP Funds Fully Utilized, ICRA Confirms No Deviations","69fc9f2fbf8f716f13ffa671","*   Successfully raised and fully utilized the entire ₹1,000 crore from its Qualified Institutional Placement (QIP) as of March 31, 2026.\n*   The monitoring agency, ICRA Limited, has issued a final report confirming **\"No deviation\"** in the use of funds from the stated objectives.\n*   The proceeds were used for debt repayment (₹530 cr), funding working capital (₹250 cr), and general corporate purposes (₹201.42 cr).\n*   This action strengthens the company's balance sheet by reducing debt and enhances its financial stability, a positive development for shareholders and creditors.",{"company_name":341,"filing_date":571,"filing_source":17,"headline":572,"id":573,"stock_code":345,"summary_text":574},"2026-05-07T19:46:40.333000","FY26 Results: 11% Revenue Growth & ₹11.50 Dividend Declared","69fc9f40c9cbead9b3c585a1","*   \u003Cb>Strong FY26 Performance\u003C\u002Fb>: Consolidated revenue grew 11.1% YoY to ₹14,600.83 Crores, with the core Consumer & Bazaar segment's profit margin expanding to 30.64%.\n*   \u003Cb>Shareholder Rewards\u003C\u002Fb>: The Board recommended a Final Dividend of ₹11.50 per share, following a 1:1 bonus issue completed in Sep 2025.\n*   \u003Cb>Investment Risk\u003C\u002Fb>: Reported an exceptional loss of ₹13.71 Crores from impairment on investments in associates, a recurring issue from the previous year.\n*   \u003Cb>Clean Audit\u003C\u002Fb>: Statutory auditors issued an \"unmodified opinion\" on the financial results, indicating no major discrepancies were found.",{"company_name":576,"filing_date":577,"filing_source":17,"headline":578,"id":579,"stock_code":580,"summary_text":581},"Patil Automation Limited","2026-05-07T19:46:40.283000","Board Appoints New Secretarial Auditor for FY 2026-27","69fc9ef9ec7f5de862c575cd","PATILAUTOM","*   The Board of Directors has appointed M\u002Fs. D Maurya & Associates, Practicing Company Secretaries, as the new Secretarial Auditor for the financial year 2026-27.\n*   This appointment was approved during the board meeting on May 07, 2026, based on the recommendation of the Audit Committee.\n*   The appointment is a standard but essential governance practice to ensure compliance with statutory and regulatory requirements.\n*   The company has confirmed that the new auditor has no relationship with the existing directors, which is a positive indicator of independence.",{"company_name":583,"filing_date":584,"filing_source":17,"headline":585,"id":586,"stock_code":587,"summary_text":588},"Kirloskar Pneumatic Company Limited","2026-05-07T19:46:40.229000","Investor & Analyst Meeting Schedule Announced","69fc9f07f35e30561cff9605","KIRLPNU","- The company has scheduled virtual meetings with institutional investors and analysts on May 12 and May 13, 2026.\n- Participants include Nippon Mutual Fund and a group meeting hosted by Antique Stock Broking Limited.\n- Management has affirmed that no unpublished price-sensitive information (UPSI) will be shared during these meetings.",{"company_name":168,"filing_date":590,"filing_source":17,"headline":591,"id":592,"stock_code":172,"summary_text":593},"2026-05-07T19:46:39.922000","FY26 Profit Soars, but GST Litigation Creates Uncertainty","69fc9eff5236ec998939fa30","*   \u003Cb>FY26 Financials:\u003C\u002Fb> Net Profit (PAT) grew 25% YoY to ₹755.61 Lakhs. Basic EPS increased to ₹1.15 from ₹0.92.\n*   \u003Cb>Dividend Recommended:\u003C\u002Fb> The Board proposed a final dividend of 5% (₹0.05 per share), subject to shareholder approval.\n*   \u003Cb>Major Risk - GST Demand:\u003C\u002Fb> The company is contesting a GST demand and penalty totaling ~₹42.68 Crore. No provision has been made, and the auditor has issued an \"Emphasis of Matter\" highlighting this uncertainty.\n*   \u003Cb>International Expansion:\u003C\u002Fb> Incorporated two new overseas subsidiaries (USA & UAE), but funding is delayed. Consequently, consolidated financial results were not prepared.",{"company_name":293,"filing_date":595,"filing_source":17,"headline":596,"id":597,"stock_code":146,"summary_text":598},"2026-05-07T19:46:39.897000","V-Mart Expands Employee Ownership with New Share Allotment","69fc9eeef43b112c8d92147d","*   **New Share Allotment:** The company has allotted **89,713 new equity shares** to eligible employees.\n*   **Reason:** This allotment is a result of employees exercising their options under the company's Employee Stock Option\u002FPurchase Scheme (ESOP\u002FESPS) on May 07, 2026.\n*   **Capital Increase:** The company's paid-up share capital has increased by **₹897,130**, reaching a new total of ₹795,480,020.\n*   **Shareholder Impact:** The new issuance results in a minor equity dilution of approximately **0.11%** for existing shareholders.",{"company_name":600,"filing_date":601,"filing_source":17,"headline":602,"id":603,"stock_code":421,"summary_text":604},"Hindustan Construction Company Limited","2026-05-07T19:46:39.880000","Analyst & Investor Meeting Scheduled","69fc9eeec9cbead9b3c5859f","*   HCC has scheduled a virtual meeting with analysts and institutional investors.\n*   The meeting will take place on Thursday, May 14, 2026, at 6:00 p.m.\n*   Interested parties can register by emailing investorrelations@hccindia.com.\n*   The company notes that the schedule is subject to change.",true,100,4,2126]